Trenbolone Enanthate
Long-ester version of Trenbolone. Same parent hormone as Trenbolone Acetate but with a longer half-life requiring less frequent injections. Extremely potent 19-Nor with strong AR binding, anti-catabolic glucocorticoid receptor antagonism, and local IGF-1 elevation. Reserved for experienced users only.
Mechanism of Action
Powerful androgen receptor agonist from the 19-Nor family. Binds the glucocorticoid receptor as an antagonist, inhibiting cortisol-mediated protein breakdown — this is why Trenbolone excels at muscle preservation in a calorie deficit. Significantly suppresses glucocorticoid expression and cortisol binding to skeletal muscle. Increases local IGF-1 production. Does NOT aromatize but may interact with estrogen receptors similarly to Nandrolone. Progestogenic — activates progesterone receptors.
Typical Dosing
⚠ Warning Flags
- •19-Nor — will keep HPTA suppressed for months after cessation
- •Severe insomnia, night sweats, and CNS disturbances common
- •Extreme cardiovascular toxicity — lipid destruction
- •Prolactin elevation — may require cabergoline
- •Neurotoxic without sufficient estrogen present
- •No aromatization = no neuroprotection from this compound alone
- •Not recommended during offseason when Nandrolone achieves similar nitrogen retention with far fewer side effects
Effect Profile
Side Effect Profile
Research Studies
17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate
Yarrow JF et al. · 2010
Demonstrated Trenbolone's massive anabolic response in muscle tissue with simultaneous anti-adipogenic effects.
Anabolic steroid abuse: physiological and anaesthetic considerations
Kam PCA, Yarrow M · 2005
Reviews AAS cardiovascular risks including Trenbolone's pronounced impact on lipids and cardiac function.
Pharmacology of anabolic steroids
Kicman AT · 2008
Comprehensive pharmacology review confirming Trenbolone's exceptionally high AR binding affinity and potency.